![Marco Santoro's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places Marco Santoro's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places](https://www.researchgate.net/profile/Giovanni-Tinelli/publication/280116037/figure/fig3/AS:601685772746780@1520464475695/figure-fig3_Q320.jpg)
Marco Santoro's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places
![Andrea Logreco's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places Andrea Logreco's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places](https://www.researchgate.net/publication/339673199/figure/fig1/AS:960041200918530@1605903067400/Sample-construction-considered-for-cross-sectional-analysis_Q320.jpg)
Andrea Logreco's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places
![Andrea Logreco's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places Andrea Logreco's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places](https://www.researchgate.net/publication/339673199/figure/fig2/AS:960041200939010@1605903067560/Number-of-medicines-authorized-per-year-by-the-EMA_Q320.jpg)
Andrea Logreco's research works | Azienda Sanitaria Locale di Pescara, Pescara (ASL Pescara) and other places
Evaluation of the national surveillance system for invasive meningococcal disease, Italy, 2015–2018 | PLOS ONE
![The Biolog-id Solution Implemented at Azienda Sanitaria Locale di Pescara in Italy to Track Blood Products and Plasma for Fractionation The Biolog-id Solution Implemented at Azienda Sanitaria Locale di Pescara in Italy to Track Blood Products and Plasma for Fractionation](https://assets-global.website-files.com/60ddd04de5124cc61df12202/62ab0408c8c7ad5d4361d696_logo%20pescara.png)
The Biolog-id Solution Implemented at Azienda Sanitaria Locale di Pescara in Italy to Track Blood Products and Plasma for Fractionation
![Acute events in children with sickle cell disease in Italy during the COVID‐19 pandemic: useful lessons learned - Munaretto - 2021 - British Journal of Haematology - Wiley Online Library Acute events in children with sickle cell disease in Italy during the COVID‐19 pandemic: useful lessons learned - Munaretto - 2021 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/9d9866af-7cfb-46b8-b7b6-5b84d139e159/bjh17546-fig-0002-m.jpg)
Acute events in children with sickle cell disease in Italy during the COVID‐19 pandemic: useful lessons learned - Munaretto - 2021 - British Journal of Haematology - Wiley Online Library
![Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study - European Journal of Internal Medicine Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study - European Journal of Internal Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/64b29898-f3f9-42da-8ae6-93919e02bf25/gr2_lrg.jpg)
Use of hydroxychloroquine in hospitalised COVID-19 patients is associated with reduced mortality: Findings from the observational multicentre Italian CORIST study - European Journal of Internal Medicine
![The District Hospital Santarém to adopt Biolog Transfusion Solution to improve red blood cells traceability The District Hospital Santarém to adopt Biolog Transfusion Solution to improve red blood cells traceability](https://assets-global.website-files.com/60ddd04de5124cc61df12202/61b38b9d5e171dd8822d43e8_biolog-id%20batiment.jpg)
The District Hospital Santarém to adopt Biolog Transfusion Solution to improve red blood cells traceability
![Frontiers | Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study Frontiers | Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/639970/639970_Thumb_400.jpg)
Frontiers | Lopinavir/Ritonavir and Darunavir/Cobicistat in Hospitalized COVID-19 Patients: Findings From the Multicenter Italian CORIST Study
![IJERPH | Free Full-Text | Healthcare Associated Infections: An Interoperable Infrastructure for Multidrug Resistant Organism Surveillance | HTML IJERPH | Free Full-Text | Healthcare Associated Infections: An Interoperable Infrastructure for Multidrug Resistant Organism Surveillance | HTML](https://www.mdpi.com/ijerph/ijerph-17-00465/article_deploy/html/images/ijerph-17-00465-g003-550.jpg)
IJERPH | Free Full-Text | Healthcare Associated Infections: An Interoperable Infrastructure for Multidrug Resistant Organism Surveillance | HTML
![Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program | Blood Cancer Journal Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program | Blood Cancer Journal](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41408-021-00445-z/MediaObjects/41408_2021_445_Fig1_HTML.png)
Long-term safety and efficacy of givinostat in polycythemia vera: 4-year mean follow up of three phase 1/2 studies and a compassionate use program | Blood Cancer Journal
![Frontiers | Implementing Lung Ultrasound in the Outpatient Management of COVID-19 Pneumonia: A Pilot Study to Update Local Guidelines Frontiers | Implementing Lung Ultrasound in the Outpatient Management of COVID-19 Pneumonia: A Pilot Study to Update Local Guidelines](https://www.frontiersin.org/files/Articles/774035/fmed-08-774035-HTML/image_m/fmed-08-774035-g001.jpg)
Frontiers | Implementing Lung Ultrasound in the Outpatient Management of COVID-19 Pneumonia: A Pilot Study to Update Local Guidelines
![Frontiers | Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis Frontiers | Neutralizing Anti-IL-17A Antibody Demonstrates Preclinical Activity Enhanced by Vinblastine in Langerhans Cell Histiocytosis](https://www.frontiersin.org/files/Articles/780191/fonc-11-780191-HTML-r1/image_m/fonc-11-780191-g001.jpg)